Coronavirus vaccine maker, AstraZeneca, has been given the all-clear by the United Kingdom competition watchdog to go ahead with its $39 billion mega-deal to buy United States drug company, Alexion Pharmaceuticals.
The Competition and Markets Authority (CMA) said it had decided not to refer the acquisition for an in-depth investigation, paving the way for the deal to close on July 21.
The CMA said in May that it was looking into whether Cambridge-based AstraZeneca’s acquisition of Alexion could harm competition in the United Kingdom.
AstraZeneca agreed to buy Boston-based Alexion for 175 dollars a share in December, marking the drug giant’s biggest acquisition, in a move to boost its expertise in immunology and rare diseases.
The cash-and-shares deal was approved by shareholders in May and had already been given clearance in 10 countries, including the United States Federal Trade Commission, before the CMA decision.
Marc Dunoyer, the executive director and chief financial officer of AstraZeneca, said “we are very pleased to have secured this critical final clearance from the UK Competition and Markets Authority for the acquisition of Alexion.
“We look forward to the imminent closing of the transaction so that we may pursue our shared ambition to bring more innovative medicines to patients worldwide and begin AstraZeneca’s next chapter of growth.”
Following the deal’s completion, AstraZeneca would create a group focused on rare diseases called Alexion, AstraZeneca Rare Disease, which would have its headquarters in Boston in the U.S.
It is a milestone for AstraZeneca, which has developed the COVID-19 jab together with Oxford University and would diversify the group, adding to its fast-growing cancer treatment business.
According to the group, the rare diseases sector represents a “high-growth opportunity with rapid innovation and significant unmet medical needs.”
More than 7,000 rare diseases are known today and only around 5 percent have treatments approved by the U.S. Food and Drug Administration, according to AstraZeneca.
It forecasts that demand in medicines for rare diseases will grow by a low double-digit percentage going forwards.
Man Utd will re-access Greenwood case – Jim Ratcliffe
Tinubu appoints Nandap new NIS comptroller-general
Bayern to part ways with Tuchel at the end of season
Man Utd legend Rooney ready to join Guardiola at City
Police arrest LP chair Abure
Bank of England to introduce new King Charles banknotes June
Niger workers begin indefinite strike today
EFCC arrests pilot over N1B fraud
14 Nigerian pastors involved in sex scandals
Drake’s nude video surfaces on social media
Ondo varsity student stabbed to death by suspected cultists
Aiyedatiwa nominates Olayide Owolabi Adelami as deputy gov
VIDEO: Nigerian dad who loses daughter to suicide blames UK boyfriend
Speaker Abass swears in 12 new reps members
Edo 2024: APC gov aspirant Idahosa knocks Obaseki over state’s debt
Rivers APC chieftain slams Tony Okocha over leadership claims
VIDEO: Thugs invade Osun APC secretariat
VIDEO: Strayed cow goes berserk inside NYSC orientation camp in Ogun
VIDEO: Are black cats bad luck?
VIDEO: Does COVID-19 only affect rich people?
VIDEO: Will I remain single if someone sweeps over my feet with a broom?
VIDEO: Gani Adams rallies Benin Republic monarchs for Sunday Igboho
FIDIO: Ǹjẹ́ Gbogbo Akitiyan Ìjọba Láti Mú Ẹ̀yìn Olóyè Sunday Ìgbòho Balẹ̀ Yìí Tọ́ Àbí Kò Tọ́?
VIDEO: Pastor Tunde Bakare declares National Movement
Sports22 hours ago
La Liga reduces Barcelona salary cap amidst financial constraints
Entertainment21 hours ago
Odumodublvck to perform alongside Offset, 21 Savage in Germany
Metro20 hours ago
EFCC nabs six in Lagos for selling new Naira notes
Sports22 hours ago
Injured Liverpool star Jota out for ‘months’, Klopp confirms
News20 hours ago
Tinubu orders settlement of N342m electricity debt
Politics11 hours ago
APC declares Edo gov primary election inconclusive
Metro11 hours ago
YouTube parenting advice influencer jailed for child abuse
Metro10 hours ago
Cholera threat: Delta community laments pollution of rivers